These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27325876)

  • 61. [Repeated improper intravenous injection of fentanyl from a transdermal system].
    Jost U; Wolter E; Böhrer H
    Dtsch Med Wochenschr; 2004 Feb; 129(7):313-4. PubMed ID: 14765330
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A new once-a-day fentanyl citrate patch (Fentos Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch.
    Koike K; Terui T; Nagasako T; Horiuchi I; Machino T; Kusakabe T; Hirayama Y; Mihara H; Yamakage M; Kato J; Nishisato T; Ishitani K
    Support Care Cancer; 2016 Mar; 24(3):1053-9. PubMed ID: 26248654
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch.
    Oliveira G; Hadgraft J; Lane ME
    Toxicol In Vitro; 2012 Jun; 26(4):645-8. PubMed ID: 22405881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multiple risks for patients using the transdermal fentanyl patch.
    Weaver JM
    Anesth Prog; 2014; 61(1):1-2. PubMed ID: 24697818
    [No Abstract]   [Full Text] [Related]  

  • 65. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transdermal fentanyl: caution in the use of high doses.
    Botterman J; De Meester C; Eeckhaut K
    Palliat Med; 2004 Oct; 18(7):663. PubMed ID: 15540677
    [No Abstract]   [Full Text] [Related]  

  • 67. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.
    Radbruch L; Sabatowski R; Loick G; Kulbe C; Kasper M; Grond S; Lehmann KA
    Palliat Med; 2000 Mar; 14(2):111-9. PubMed ID: 10829145
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.
    Alberts DS; Smith CC; Parikh N; Rauck RL
    Pain Manag; 2016 Oct; 6(5):427-34. PubMed ID: 27020837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transdermal therapeutic fentanyl-system (TTS-F).
    Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
    In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
    [TBL] [Abstract][Full Text] [Related]  

  • 71. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
    Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Treatment of chronic pain--use of transdermal fentanyl (Durogesic TTS)].
    Babić-Naglić D; Jajić Z; Gnjidić Z; Stambuk B
    Reumatizam; 2002; 49(2):33-7. PubMed ID: 12476759
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What you need to know about fentanyl patches.
    D'Arcy Y
    Nursing; 2005 Aug; 35(8):73. PubMed ID: 16062156
    [No Abstract]   [Full Text] [Related]  

  • 74. Safety of propoxyphene in dialysis patients.
    Bailie GR; Johnson CA
    Semin Dial; 2002; 15(5):375. PubMed ID: 12358644
    [No Abstract]   [Full Text] [Related]  

  • 75. Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure.
    Mercadante S; Caligara M; Sapio M; Serretta R; Lodi F
    J Pain Symptom Manage; 1997 Apr; 13(4):241-4. PubMed ID: 9136236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical safety in the care of the person with end-stage kidney disease.
    Duronville JV; Diamantidis CJ
    Semin Dial; 2018 Mar; 31(2):140-148. PubMed ID: 29315834
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transdermal Fentanyl Death Pact.
    Blumenthal R; Roth LB
    Am J Forensic Med Pathol; 2022 Jun; 43(2):e18-e20. PubMed ID: 34802011
    [No Abstract]   [Full Text] [Related]  

  • 78. Post-dialysis fatigue and survival in patients on chronic hemodialysis.
    Bossola M; Picca A; Monteburini T; Parodi E; Santarelli S; Cenerelli S; Sirolli V; Bonomini M; Di Stasio E
    J Nephrol; 2021 Dec; 34(6):2163-2165. PubMed ID: 34390478
    [No Abstract]   [Full Text] [Related]  

  • 79. Acid-base events during hemodialysis.
    Gennari FJ; Sargent JA
    Am J Physiol Renal Physiol; 2021 Jan; 320(1):F130-F131. PubMed ID: 33439106
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical outcome of short daily hemodialysis in the elderly.
    Villié P; Dauvergne M; Maheas C; Vendé F; Urena P; Ridel C; Touzot M
    J Nephrol; 2021 Dec; 34(6):2171-2172. PubMed ID: 34453727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.